1. Second Primary Malignancies in Cancer Survivors
   Danielle M. Fournier et al, 2017, The Journal for Nurse Practitioners CrossRef
2. Breast Cancer Survivorship Care: Targeting a Colorectal Cancer Education Intervention
   Sherri Homan et al, 2015, JPM CrossRef
3. Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer
   Carolyn J. Kushner et al, 2018, Breast Cancer Res Treat CrossRef
4. null
   Araceli Morales et al, 2016 CrossRef
5. Opto-chemical and laser properties of FLTX1, a novel fluorescent tamoxifen derivative, and its potential applications in breast cancer photodynamic chemotherapy
   Mario Díaz et al, 2018, Optical Materials CrossRef
6. Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis
   Jimmy LN Vo et al, 2014, OncoImmunology CrossRef
7. Claudin 1 Promotes Migration and Increases Sensitivity to Tamoxifen and Anticancer Drugs in Luminal-like Human Breast Cancer Cells MCF7
   Bowen Zhou et al, 2015, Cancer Investigation CrossRef
8. Interval breast cancer is associated with other types of tumors
   Felix Grassmann et al, 2019, Nat Commun CrossRef
9. Estimands and the Patient Journey: Addressing the Right Question in Oncology Clinical Trials
   Evgeny Degtyarev et al, 2019, JCO Precision Oncology CrossRef
10. Uterine cancer in breast cancer survivors: a systematic review
    Akemi T. Wijayabahu et al, 2020, Breast Cancer Res Treat CrossRef
11. FRET mechanism between a fluorescent breast-cancer drug and photodynamic therapy sensitizers
    F. Lahoz et al, 2020, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy CrossRef
12. Protection against chemotherapy- and radiotherapy-induced side effects: A review based on the mechanisms and therapeutic opportunities of phytochemicals
    Yong-Qiang Liu et al, 2020, Phytomedicine CrossRef
13. Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status
    Hyuna Sung et al, 2021, Cancer CrossRef
14. FLTX2: A Novel Tamoxifen Derivative Endowed with Antiestrogenic, Fluorescent, and Photosensitizer Properties
    Mario Díaz et al, 2021, IJMS CrossRef
15. Gynaecological malignancies after breast cancer diagnosis: A population-based study
    MP Barretina-Ginesta et al, 2019, Clin J Obstet Gynaecol CrossRef
16. Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial
    Flora Zagouri et al, 2022, Br J Cancer CrossRef
17. Biochemical Basis of Selective Accumulation and Targeted Delivery of Photosensitizers to Tumor Tissues
    Veronika I. Ivanova-Radkevich, 2022, Biochemistry Moscow CrossRef
18. Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone Versus Hormone Therapy Alone or Combined Treatment for Low-Risk ER-Positive Early Stage Breast Cancer in Women Aged 65 Years and Older
    Matthew C. Ward et al, 2022, International Journal of Radiation Oncology*Biology*Physics CrossRef
19. Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis
    Isaac Allen et al, 2023, Breast Cancer Res CrossRef
20. Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort
    Cody Ramin et al, 2023, Breast Cancer Res CrossRef
21. Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre
    Han Hsi Wong et al, 2023, Breast Cancer CrossRef
22. Protective Effect of Rosmarinic Acid and Epigallocatechin Gallate Against Doxorubicin-İnduced Cytotoxicity and Genotoxicity on CHO-K1 Cells
    Sinem Helvacioglu et al, 2024, tjps CrossRef